nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Carcinoma of lung—Riluzole—amyotrophic lateral sclerosis	0.0322	0.0843	CcSEcCtD
Vinorelbine—Vestibular disorder—Riluzole—amyotrophic lateral sclerosis	0.0279	0.0729	CcSEcCtD
Vinorelbine—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.0279	0.0729	CcSEcCtD
Vinorelbine—Vincristine—TUBA4A—amyotrophic lateral sclerosis	0.0156	1	CrCbGaD
Vinorelbine—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.0089	0.0233	CcSEcCtD
Vinorelbine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0088	0.023	CcSEcCtD
Vinorelbine—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00871	0.0228	CcSEcCtD
Vinorelbine—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.0082	0.0215	CcSEcCtD
Vinorelbine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0079	0.0207	CcSEcCtD
Vinorelbine—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0079	0.0207	CcSEcCtD
Vinorelbine—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.0079	0.0207	CcSEcCtD
Vinorelbine—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0182	CcSEcCtD
Vinorelbine—TUBB4A—hindbrain—amyotrophic lateral sclerosis	0.00691	0.0526	CbGeAlD
Vinorelbine—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00674	0.0176	CcSEcCtD
Vinorelbine—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00591	0.0155	CcSEcCtD
Vinorelbine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00573	0.015	CcSEcCtD
Vinorelbine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00569	0.0149	CcSEcCtD
Vinorelbine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00559	0.0146	CcSEcCtD
Vinorelbine—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00556	0.0145	CcSEcCtD
Vinorelbine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00525	0.0137	CcSEcCtD
Vinorelbine—TUBB8—nervous system—amyotrophic lateral sclerosis	0.005	0.0381	CbGeAlD
Vinorelbine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00498	0.013	CcSEcCtD
Vinorelbine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0127	CcSEcCtD
Vinorelbine—TUBB8—central nervous system—amyotrophic lateral sclerosis	0.00481	0.0366	CbGeAlD
Vinorelbine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0123	CcSEcCtD
Vinorelbine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00454	0.0119	CcSEcCtD
Vinorelbine—TUBB4A—embryo—amyotrophic lateral sclerosis	0.00432	0.0329	CbGeAlD
Vinorelbine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00416	0.0109	CcSEcCtD
Vinorelbine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00408	0.0107	CcSEcCtD
Vinorelbine—TUBB4A—brainstem—amyotrophic lateral sclerosis	0.00396	0.0302	CbGeAlD
Vinorelbine—TUBB8—brain—amyotrophic lateral sclerosis	0.00382	0.0291	CbGeAlD
Vinorelbine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00956	CcSEcCtD
Vinorelbine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00936	CcSEcCtD
Vinorelbine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00917	CcSEcCtD
Vinorelbine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00344	0.009	CcSEcCtD
Vinorelbine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00894	CcSEcCtD
Vinorelbine—TUBB3—nervous system—amyotrophic lateral sclerosis	0.00341	0.026	CbGeAlD
Vinorelbine—TUBB4B—embryo—amyotrophic lateral sclerosis	0.00337	0.0257	CbGeAlD
Vinorelbine—TUBB1—nervous system—amyotrophic lateral sclerosis	0.00333	0.0254	CbGeAlD
Vinorelbine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00871	CcSEcCtD
Vinorelbine—TUBB3—central nervous system—amyotrophic lateral sclerosis	0.00328	0.025	CbGeAlD
Vinorelbine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00858	CcSEcCtD
Vinorelbine—TUBB1—central nervous system—amyotrophic lateral sclerosis	0.00321	0.0244	CbGeAlD
Vinorelbine—TUBB3—cerebellum—amyotrophic lateral sclerosis	0.00321	0.0244	CbGeAlD
Vinorelbine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0083	CcSEcCtD
Vinorelbine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00823	CcSEcCtD
Vinorelbine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00818	CcSEcCtD
Vinorelbine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00818	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00806	CcSEcCtD
Vinorelbine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00802	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00802	CcSEcCtD
Vinorelbine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00797	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00774	CcSEcCtD
Vinorelbine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00763	CcSEcCtD
Vinorelbine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00731	CcSEcCtD
Vinorelbine—TUBB4A—medulla oblongata—amyotrophic lateral sclerosis	0.00276	0.021	CbGeAlD
Vinorelbine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00722	CcSEcCtD
Vinorelbine—TUBB2B—medulla oblongata—amyotrophic lateral sclerosis	0.00267	0.0203	CbGeAlD
Vinorelbine—TUBB3—brain—amyotrophic lateral sclerosis	0.00261	0.0199	CbGeAlD
Vinorelbine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00682	CcSEcCtD
Vinorelbine—TUBB1—brain—amyotrophic lateral sclerosis	0.00255	0.0194	CbGeAlD
Vinorelbine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00666	CcSEcCtD
Vinorelbine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00663	CcSEcCtD
Vinorelbine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00662	CcSEcCtD
Vinorelbine—TUBB—medulla oblongata—amyotrophic lateral sclerosis	0.00253	0.0192	CbGeAlD
Vinorelbine—TUBB2A—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00253	0.00537	CbGpPWpGaD
Vinorelbine—TUBB2A—medulla oblongata—amyotrophic lateral sclerosis	0.00251	0.0191	CbGeAlD
Vinorelbine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00656	CcSEcCtD
Vinorelbine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00649	CcSEcCtD
Vinorelbine—TUBB6—medulla oblongata—amyotrophic lateral sclerosis	0.00248	0.0189	CbGeAlD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00247	0.00525	CbGpPWpGaD
Vinorelbine—TUBB1—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00247	0.00525	CbGpPWpGaD
Vinorelbine—TUBB—Loss of Nlp from mitotic centrosomes—TUBA4A—amyotrophic lateral sclerosis	0.00246	0.00523	CbGpPWpGaD
Vinorelbine—TUBB4A—spinal cord—amyotrophic lateral sclerosis	0.00246	0.0188	CbGeAlD
Vinorelbine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00639	CcSEcCtD
Vinorelbine—TUBB4A—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00243	0.00517	CbGpPWpGaD
Vinorelbine—TUBB2B—spinal cord—amyotrophic lateral sclerosis	0.00238	0.0181	CbGeAlD
Vinorelbine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00618	CcSEcCtD
Vinorelbine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00593	CcSEcCtD
Vinorelbine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00591	CcSEcCtD
Vinorelbine—TUBB—spinal cord—amyotrophic lateral sclerosis	0.00225	0.0172	CbGeAlD
Vinorelbine—TUBB2A—spinal cord—amyotrophic lateral sclerosis	0.00224	0.0171	CbGeAlD
Vinorelbine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00584	CcSEcCtD
Vinorelbine—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00223	0.00473	CbGpPWpGaD
Vinorelbine—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00223	0.00473	CbGpPWpGaD
Vinorelbine—TUBB4B—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00222	0.00473	CbGpPWpGaD
Vinorelbine—TUBB4A—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00222	0.00471	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00222	0.00471	CbGpPWpGaD
Vinorelbine—TUBB6—spinal cord—amyotrophic lateral sclerosis	0.00221	0.0168	CbGeAlD
Vinorelbine—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00221	0.00469	CbGpPWpGaD
Vinorelbine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00577	CcSEcCtD
Vinorelbine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00574	CcSEcCtD
Vinorelbine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00572	CcSEcCtD
Vinorelbine—TUBB—Centrosome maturation—TUBA4A—amyotrophic lateral sclerosis	0.00218	0.00463	CbGpPWpGaD
Vinorelbine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00218	0.0166	CbGeAlD
Vinorelbine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00565	CcSEcCtD
Vinorelbine—TUBB4B—medulla oblongata—amyotrophic lateral sclerosis	0.00215	0.0164	CbGeAlD
Vinorelbine—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00215	0.00457	CbGpPWpGaD
Vinorelbine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00558	CcSEcCtD
Vinorelbine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00552	CcSEcCtD
Vinorelbine—TUBB—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00209	0.00445	CbGpPWpGaD
Vinorelbine—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00208	0.00442	CbGpPWpGaD
Vinorelbine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00544	CcSEcCtD
Vinorelbine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00544	CcSEcCtD
Vinorelbine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00544	CcSEcCtD
Vinorelbine—TUBB4A—nervous system—amyotrophic lateral sclerosis	0.00208	0.0158	CbGeAlD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00541	CcSEcCtD
Vinorelbine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00538	CcSEcCtD
Vinorelbine—TUBB4A—Loss of Nlp from mitotic centrosomes—TUBA4A—amyotrophic lateral sclerosis	0.00204	0.00434	CbGpPWpGaD
Vinorelbine—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00204	0.00433	CbGpPWpGaD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00203	0.00431	CbGpPWpGaD
Vinorelbine—TUBB4B—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00203	0.00431	CbGpPWpGaD
Vinorelbine—TUBB2B—nervous system—amyotrophic lateral sclerosis	0.00201	0.0153	CbGeAlD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.002	0.00426	CbGpPWpGaD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.002	0.00426	CbGpPWpGaD
Vinorelbine—TUBB4A—central nervous system—amyotrophic lateral sclerosis	0.002	0.0152	CbGeAlD
Vinorelbine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00522	CcSEcCtD
Vinorelbine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00518	CcSEcCtD
Vinorelbine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00512	CcSEcCtD
Vinorelbine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00511	CcSEcCtD
Vinorelbine—TUBB4A—cerebellum—amyotrophic lateral sclerosis	0.00195	0.0149	CbGeAlD
Vinorelbine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00509	CcSEcCtD
Vinorelbine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00507	CcSEcCtD
Vinorelbine—TUBB2B—central nervous system—amyotrophic lateral sclerosis	0.00193	0.0147	CbGeAlD
Vinorelbine—TUBB4B—spinal cord—amyotrophic lateral sclerosis	0.00192	0.0146	CbGeAlD
Vinorelbine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00497	CcSEcCtD
Vinorelbine—TUBB2A—nervous system—amyotrophic lateral sclerosis	0.00189	0.0144	CbGeAlD
Vinorelbine—TUBB2B—cerebellum—amyotrophic lateral sclerosis	0.00189	0.0144	CbGeAlD
Vinorelbine—TUBB4B—Loss of Nlp from mitotic centrosomes—TUBA4A—amyotrophic lateral sclerosis	0.00187	0.00397	CbGpPWpGaD
Vinorelbine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00488	CcSEcCtD
Vinorelbine—TUBB6—nervous system—amyotrophic lateral sclerosis	0.00186	0.0142	CbGeAlD
Vinorelbine—TUBB—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00186	0.00394	CbGpPWpGaD
Vinorelbine—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00183	0.00388	CbGpPWpGaD
Vinorelbine—TUBB2A—central nervous system—amyotrophic lateral sclerosis	0.00182	0.0138	CbGeAlD
Vinorelbine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00475	CcSEcCtD
Vinorelbine—TUBB4A—Centrosome maturation—TUBA4A—amyotrophic lateral sclerosis	0.00181	0.00384	CbGpPWpGaD
Vinorelbine—TUBB6—central nervous system—amyotrophic lateral sclerosis	0.00179	0.0137	CbGeAlD
Vinorelbine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00468	CcSEcCtD
Vinorelbine—TUBB—cerebellum—amyotrophic lateral sclerosis	0.00179	0.0136	CbGeAlD
Vinorelbine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00465	CcSEcCtD
Vinorelbine—TUBB2A—cerebellum—amyotrophic lateral sclerosis	0.00178	0.0135	CbGeAlD
Vinorelbine—TUBB6—cerebellum—amyotrophic lateral sclerosis	0.00175	0.0133	CbGeAlD
Vinorelbine—TUBB4A—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00174	0.00369	CbGpPWpGaD
Vinorelbine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00454	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0045	CcSEcCtD
Vinorelbine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0045	CcSEcCtD
Vinorelbine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00446	CcSEcCtD
Vinorelbine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00446	CcSEcCtD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.0017	0.00362	CbGpPWpGaD
Vinorelbine—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00167	0.00355	CbGpPWpGaD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00166	0.00353	CbGpPWpGaD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00166	0.00353	CbGpPWpGaD
Vinorelbine—TUBB4B—Centrosome maturation—TUBA4A—amyotrophic lateral sclerosis	0.00165	0.00351	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0043	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00427	CcSEcCtD
Vinorelbine—TUBB4B—nervous system—amyotrophic lateral sclerosis	0.00162	0.0123	CbGeAlD
Vinorelbine—TUBB4B—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00159	0.00337	CbGpPWpGaD
Vinorelbine—TUBB4A—brain—amyotrophic lateral sclerosis	0.00159	0.0121	CbGeAlD
Vinorelbine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00414	CcSEcCtD
Vinorelbine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00412	CcSEcCtD
Vinorelbine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00412	CcSEcCtD
Vinorelbine—TUBB4B—central nervous system—amyotrophic lateral sclerosis	0.00156	0.0119	CbGeAlD
Vinorelbine—TUBB4A—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00154	0.00327	CbGpPWpGaD
Vinorelbine—TUBB2B—brain—amyotrophic lateral sclerosis	0.00153	0.0117	CbGeAlD
Vinorelbine—TUBB4B—cerebellum—amyotrophic lateral sclerosis	0.00152	0.0116	CbGeAlD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00152	0.00322	CbGpPWpGaD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00152	0.00322	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.0015	0.0032	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.0015	0.0032	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.00148	0.00315	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—TUBA4A—amyotrophic lateral sclerosis	0.00148	0.00315	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00384	CcSEcCtD
Vinorelbine—TUBB—brain—amyotrophic lateral sclerosis	0.00145	0.011	CbGeAlD
Vinorelbine—TUBB2A—brain—amyotrophic lateral sclerosis	0.00144	0.011	CbGeAlD
Vinorelbine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00374	CcSEcCtD
Vinorelbine—TUBB6—brain—amyotrophic lateral sclerosis	0.00142	0.0108	CbGeAlD
Vinorelbine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00369	CcSEcCtD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00141	0.003	CbGpPWpGaD
Vinorelbine—TUBB4B—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00141	0.00299	CbGpPWpGaD
Vinorelbine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00357	CcSEcCtD
Vinorelbine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00345	CcSEcCtD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00129	0.00274	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00128	0.00272	CbGpPWpGaD
Vinorelbine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00332	CcSEcCtD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.00126	0.00268	CbGpPWpGaD
Vinorelbine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00329	CcSEcCtD
Vinorelbine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00329	CcSEcCtD
Vinorelbine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00327	CcSEcCtD
Vinorelbine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00125	0.00951	CbGeAlD
Vinorelbine—TUBB4A—G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00125	0.00265	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00125	0.00265	CbGpPWpGaD
Vinorelbine—TUBB4B—brain—amyotrophic lateral sclerosis	0.00124	0.00942	CbGeAlD
Vinorelbine—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—GSTP1—amyotrophic lateral sclerosis	0.00124	0.00262	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—TUBA4A—amyotrophic lateral sclerosis	0.00123	0.00261	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.00123	0.00261	CbGpPWpGaD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00119	0.00253	CbGpPWpGaD
Vinorelbine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0031	CcSEcCtD
Vinorelbine—TUBB4B—G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00114	0.00242	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00114	0.00242	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—TUBA4A—amyotrophic lateral sclerosis	0.00112	0.00239	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.00112	0.00239	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00106	0.00225	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.00105	0.00222	CbGpPWpGaD
Vinorelbine—ABCB1—embryo—amyotrophic lateral sclerosis	0.00098	0.00747	CbGeAlD
Vinorelbine—TUBB4B—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.000969	0.00206	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.000956	0.00203	CbGpPWpGaD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000906	0.00192	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000904	0.00192	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000904	0.00192	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000873	0.00185	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000846	0.0018	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000827	0.00176	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000742	0.00158	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000685	0.00146	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000685	0.00146	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000679	0.00144	CbGpPWpGaD
Vinorelbine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000665	0.00506	CbGeAlD
Vinorelbine—TUBB3—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000662	0.00141	CbGpPWpGaD
Vinorelbine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000654	0.00498	CbGeAlD
Vinorelbine—TUBB2A—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000641	0.00136	CbGpPWpGaD
Vinorelbine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00064	0.00488	CbGeAlD
Vinorelbine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00063	0.0048	CbGeAlD
Vinorelbine—TUBB2B—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000627	0.00133	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000627	0.00133	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000627	0.00133	CbGpPWpGaD
Vinorelbine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000626	0.00477	CbGeAlD
Vinorelbine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000616	0.00469	CbGeAlD
Vinorelbine—TUBB3—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000605	0.00129	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000586	0.00125	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000573	0.00122	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000571	0.00121	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000571	0.00121	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000563	0.0012	CbGpPWpGaD
Vinorelbine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000559	0.00425	CbGeAlD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000558	0.00119	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000552	0.00117	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000534	0.00114	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000523	0.00111	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000519	0.0011	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000519	0.0011	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000515	0.00109	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000515	0.00109	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000501	0.00107	CbGpPWpGaD
Vinorelbine—CYP2D6—brain—amyotrophic lateral sclerosis	0.0005	0.00381	CbGeAlD
Vinorelbine—TUBB2A—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000486	0.00103	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000479	0.00102	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000479	0.00102	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000475	0.00101	CbGpPWpGaD
Vinorelbine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000471	0.00359	CbGeAlD
Vinorelbine—TUBB4B—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000471	0.001	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000469	0.000997	CbGpPWpGaD
Vinorelbine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000453	0.00345	CbGeAlD
Vinorelbine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000443	0.00337	CbGeAlD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—amyotrophic lateral sclerosis	0.000436	0.000925	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000429	0.000912	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000428	0.000909	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000428	0.000909	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000428	0.000908	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000428	0.000908	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000426	0.000906	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000413	0.000877	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000407	0.000864	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.0004	0.00085	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000397	0.000842	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000397	0.000842	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000391	0.000831	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00039	0.000828	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000368	0.000782	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000368	0.000782	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000364	0.000773	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000363	0.00077	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000363	0.00077	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00036	0.000765	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00036	0.000765	CbGpPWpGaD
Vinorelbine—ABCB1—brain—amyotrophic lateral sclerosis	0.00036	0.00274	CbGeAlD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000356	0.000755	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000355	0.000753	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000355	0.000753	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000351	0.000746	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000348	0.000738	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000344	0.000732	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000337	0.000716	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000337	0.000715	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000337	0.000715	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000329	0.000699	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000324	0.000689	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000324	0.000689	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000321	0.000682	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000313	0.000665	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000313	0.000665	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000313	0.000665	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000313	0.000665	CbGpPWpGaD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000311	0.000661	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000308	0.000655	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000306	0.00065	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000306	0.00065	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000302	0.000642	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000302	0.000642	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000302	0.000642	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000301	0.00064	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000296	0.000628	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000296	0.000628	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000293	0.000622	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000293	0.000622	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000286	0.000608	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000286	0.000608	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000286	0.000608	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00028	0.000595	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000279	0.000593	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000279	0.000593	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000279	0.000593	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000277	0.000587	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000276	0.000586	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00027	0.000574	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000269	0.000572	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000261	0.000554	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000257	0.000546	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000257	0.000546	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000255	0.000542	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000251	0.000534	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000235	0.000499	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000235	0.000499	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00023	0.000488	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000229	0.000487	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000228	0.000484	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000226	0.00048	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000226	0.00048	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000224	0.000475	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000221	0.00047	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000218	0.000464	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000211	0.000449	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00021	0.000445	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000207	0.000439	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000186	0.000394	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.00018	0.000383	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.00017	0.000361	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000159	0.000338	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000157	0.000333	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000152	0.000323	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000145	0.000308	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000143	0.000304	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00013	0.000277	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00011	0.000235	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.91e-05	0.000211	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.77e-05	0.000208	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	9.55e-05	0.000203	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	9.55e-05	0.000203	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	9.42e-05	0.0002	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	9.31e-05	0.000198	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	9.23e-05	0.000196	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	9.23e-05	0.000196	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	8.93e-05	0.00019	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	8.89e-05	0.000189	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	8.74e-05	0.000186	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.4e-05	0.000179	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	8.06e-05	0.000171	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	8.06e-05	0.000171	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	8e-05	0.00017	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	7.84e-05	0.000167	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	7.59e-05	0.000161	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	7.59e-05	0.000161	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	7.37e-05	0.000157	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	7.17e-05	0.000152	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.14e-05	0.000152	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.14e-05	0.000152	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	6.95e-05	0.000148	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.85e-05	0.000146	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.48e-05	0.000138	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.46e-05	0.000137	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.44e-05	0.000137	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.39e-05	0.000136	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.37e-05	0.000135	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	6.07e-05	0.000129	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	6.04e-05	0.000128	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	5.83e-05	0.000124	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—amyotrophic lateral sclerosis	5.61e-05	0.000119	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	5.49e-05	0.000117	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	5.01e-05	0.000106	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.97e-05	0.000105	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.97e-05	0.000105	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.65e-05	9.88e-05	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—amyotrophic lateral sclerosis	4.64e-05	9.87e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	4.54e-05	9.65e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.42e-05	9.38e-05	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—amyotrophic lateral sclerosis	4.25e-05	9.02e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.22e-05	8.97e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.16e-05	8.84e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	4.08e-05	8.66e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.97e-05	8.43e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.95e-05	8.38e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.84e-05	8.16e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.59e-05	7.63e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.35e-05	7.11e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.15e-05	6.7e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.98e-05	6.33e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.72e-05	5.78e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.51e-05	5.33e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.06e-05	4.38e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.8e-05	3.82e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.69e-05	3.6e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	3.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	3.31e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.36e-05	2.89e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.28e-05	2.72e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.11e-05	2.35e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	2.16e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.32e-06	1.98e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.78e-06	1.87e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	8.38e-06	1.78e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.74e-06	1.22e-05	CbGpPWpGaD
